Table 1 Patients population with and without MACE
Entire sample | MACE | NO MACE | p value | |
|---|---|---|---|---|
n = 227 | (n = 14) | (n = 213) | ||
Demographic characteristics | ||||
Age; yrs (median, IQR) | 71 (66–76) | 78 (74–82) | 71 (66–75) | 0.00041 |
Male; n (%) | 90 (40) | 3 (21) | 87 (41) | 0.152 |
Female; n (%) | 137 (60) | 11 (79) | 126 (59) | |
BMI; Kg/m2 (median, IQR) | 28 (25–31) | 27 (25–29) | 28 (25–31) | 0.441 |
Obesity; n (%) | 98 (43) | 5 (36) | 93 (44) | 0.562 |
ASA class; n (%) | ||||
Class I | 10 (4) | 0 (0.00) | 10 (4) | 0.053 |
Class II | 184 (81) | 10 (71) | 174 (82) | |
Class III | 33 (15) | 4 (29) | 29 (14) | |
RCRI; n (%) | ||||
0 | 165 (72.7) | 7 (50) | 158 (74.1) | 0.093 |
1 | 44 (19.4) | 4 (28.6) | 40 (18.8) | |
2 | 10 (4.4) | 2 (14.3) | 8 (3.8) | |
3 | 7 (3.1) | 1 (7.1) | 6 (2.9) | |
4 | 1 (0.4) | 0 (0.00) | 1 (0.4) | |
Coexisting diseases; n (%) | ||||
Hypertension | 169 (74) | 12 (86) | 157 (74) | 0.173 |
Diabetes | 40 (18) | 3 (21) | 37 (17) | 0.723 |
Smokers | 40 (18) | 1 (7) | 39 (18) | 0.473 |
COPD | 12 (5) | 0 (0.00) | 12 (5.6) | 1.003 |
Previous angina | 18 (8) | 3 (21) | 15 (7) | 0.093 |
Previous AMI | 17 (7) | 3 (21) | 14 (6.5) | 0.073 |
Previous AF | 15 (6.6) | 2 (14) | 13 (6.1) | 0.233 |
Medication history; n (%) | ||||
ACE inhibitor | 43 (19) | 5 (36) | 38 (18) | 0.153 |
Aspirin | 43 (19) | 4 (29) | 39 (18) | 0.303 |
Beta-blockers | 64 (28) | 6 (43) | 58 (28) | 0.233 |
Ca antagonists | 25 (11) | 1 (7) | 24 (11) | 1.003 |
Diuretics | 54 (24) | 4 (29) | 50 (23) | 0.443 |
AR antagonist | 67 (30) | 3 (21) | 64 (30) | 0.843 |
Statins | 45 (20) | 2 (15) | 43 (20) | 0.743 |